Alerta

DENGUE VIRUS MRNA VACCINE AND METHOD AGAINST DENGUE VIRUS INFECTION USING THE SAME

Absstract of: US20260232788A1

0000 The present invention relates to a dengue virus messenger ribonucleic acid (mRNA) vaccine. In particular, the vaccine includes an mRNA encoding a mutant envelop (E) protein of dengue virus at position 8 and/or 101 formulated in lipid nanoparticles. The mRNA vaccine of the present invention is safe and effective, which causes enhanced production of neutralizing antibodies against multiple serotypes of dengue virus and reduced antibody dependent enhancement (ADE) response.

NANOPARTICLE, METHOD FOR GENERATING HYDRATED ELECTRON USING SAME, AND METHOD FOR DECOMPOSING HALOGEN-CONTAINING ORGANIC MATERIAL

Absstract of: US20260234018A1

Disclosed is a nanoparticle, comprising an organic ligand represented by the following Formula (2) on the surface of a particle represented by the following Formula (1): ZnX (1) in Formula (1), X represents a Group 16 element, —Y—R21—R22 (2) in Formula (2), Y is selected from OCO, OSO2, OSO, and SCS—N(R23); R21 represents an organic group having 1 to 20 carbon atoms that is optionally substituted with SH or fluorine; R22 represents H, F, COOH, or NH2; and R23 represents a monovalent organic group having 1 to 20 carbon atoms that is optionally substituted with SH or fluorine, with the proviso that cases where R21 is CH2 and R22 is H or NH2 are excluded.

METHOD FOR PRODUCING A KERATIN POWDER FROM FEATHERS OF ANIMAL ORIGIN, COLLOIDAL SOLUTION AND KERATIN POWDER FOR TOPICAL APPLICATION CONTAINING KERATIN PARTICLES, AND USE OF THE COLLOIDAL SOLUTION AND THE KERATIN POWDER

Absstract of: US20260234208A1

0000 The invention relates to a method for producing keratin powder of the protein β-keratin from feathers of animal origin by extracting keratin, filtering the extraction solution and obtaining a colloidal solution, and drying same to form the keratin powder. The invention also relates to a colloidal solution for topical application containing keratin particles of the protein β-keratin and/or agglomerates thereof or a keratin powder containing said keratin particles. The colloidal solution and the keratin powder are used for the production of preparations with therapeutic, diagnostic, preventative or cosmetic purposes for humans and/or animals.

CARBON MATERIAL DISPERSION AND USE THEREOF

Absstract of: US20260234420A1

0000 There is provided a carbon material dispersion capable of forming film having improved electrical conductivity as compared to when a single carbon material is used. The carbon material dispersion contains: at least two carbon materials selected from the group consisting of single-walled carbon nanotubes, multi-walled carbon nanotubes, and carbon black; an aqueous medium; a dispersant; and a binder resin, wherein when the carbon materials are composed of a combination of a single-walled carbon nanotube and carbon black, the amount of carbon black to 1 part by mass of the single-walled carbon nanotube is 0.001 to 0.43 parts by mass, or when the carbon materials are composed of a combination of a single-walled carbon nanotube, a multi-walled carbon nanotube, and carbon black, the amount of carbon black based on 1 part by mass of the total amount of the single-walled carbon nanotube and the multi-walled carbon nanotube is 0.001 to 0.43 parts by mass.

Semiconductor Quantum Dot Device and Fabrication Method, Signal Reading Method and Manipulation Method Therefor

Absstract of: US20260239677A1

0000 The present application discloses a semiconductor quantum dot device structure, fabrication method, signal reading method and manipulation method. The structure includes: a silicon substrate formed to be provided with a first ion region and a second ion region; a dielectric layer located on the silicon substrate layer, with a carrier channel formed at an interface between the silicon substrate and the dielectric layer; the first electrode in ohmic contact with the first ion region, and the second electrode in ohmic contact with the second ion region; A confining electrode located on the dielectric layer, configured to confine carriers within the carrier channel to form quantum dots; and a magnetic electrode, the magnetic electrode is configured to form a magnetic field gradient at the interface and to The quantum dots are manipulated. The application also discloses a semiconductor quantum dot device.

Lipid nanoparticles encapsulation of large RNA

Absstract of: AU2026208137A1

A method of producing lipid-encapsulated RNA nanoparticles includes flowing an aqueous solution comprising an RNA through a 1st tube having a first inner diameter (ID); the RNA comprises from about 6,000 to about 13,000 nucleotides; flowing an ethanol solution comprising lipids through a 2nd tube having a second inner diameter (ID), at a flow rate of about 0.2 to about 1 times relative to the aqueous solution through the 1st tube, the lipids comprise a cationic lipid; and mixing the ethanol solution with the aqueous solution; the first ID and second ID and flow rates through the 1st tube and 2nd tube are selected to produce a shear force sufficiently low to preserve the integrity of the RNA; the mixing produces an output solution flowing in the 1st tube comprising a turbulent flow of the RNA and the lipids in between about ethanol, the lipid-encapsulated RNA nanoparticles having a bilayer structure. ul u l

SEMICONDUCTOR DEVICES AND METHODS OF MANUFACTURING

Absstract of: US20260239690A1

Semiconductor devices and their manufacturing methods are disclosed herein, and more particularly to semiconductor devices including a transistor having gate all around (GAA) transistor structures and manufacturing methods thereof. Different thickness in an epi-growth scheme is adopted to create different sheet thicknesses within the same device channel regions for use in manufacturing vertically stacked nanostructure (e.g., nanosheet, nanowire, or the like) GAA devices. A vertically stacked nanostructure GAA device may be formed with a topmost channel region that is thinner than a bottommost channel region. Furthermore, the topmost channel region of the GAA device may be formed with lightly doped drain regions with a highest concentration and/or a greater degree of lateral diffusion of implanted dopants as compared to the bottommost channel region.

NANOMATERIALS CONTAINING CONSTRAINED LIPIDS AND USES THEREOF

Absstract of: US20260232587A1

Compositions for delivering nucleic acids to cells or tissue microenvironments are provided. In one embodiment, the compositions are lipid nanoparticle compositions formulated to have reduced splenic and hepatic clearance. It has been discovered that the chemical composition of lipid nanoparticles significantly influences the natural trafficking of the lipid nanoparticles. More specifically, it has been discovered that conformationally constrained ionizable lipids can modify the tropism and clearance profile of lipid nanoparticles without the need of a targeting ligand. It has also been discovered that tropism of the disclosed lipid nanoparticles is size-independent.

TRIBOELECTRIC NANOSENSOR, DRUG SCREENING PLATFORM, DRUG SCREENING SYSTEM AND DRUG SCREENING METHOD

Absstract of: US20260235547A1

0000 A triboelectric nanosensor, a drug screening platform, a drug screening system and a drug screening method are provided. The triboelectric nanosensor includes a single electrode, a solid triboelectric layer, and a fusion protein. The solid triboelectric layer coats a surface of the single electrode. The fusion protein includes a target protein and a histidine tag, and the fusion protein is adsorbed onto a surface of the solid triboelectric layer. The drug screening platform includes the triboelectric nanosensor, a reaction solution, a reaction tank, and a displacement device, in which the reaction solution includes a solvent and a test drug. The drug screening system includes the drug screening platform, a voltage detector and a processor. The drug screening method includes using the drug screening system to perform drug screening.

カーボンナノチューブ合成装置

Absstract of: WO2023068806A1

The present invention relates to a carbon nanotube manufacturing apparatus including a plasma device and a CVD reactor which are connected in series, in which a nanoparticle catalyst in an aerosol state prepared in the plasma device is transferred into the CVD reactor to synthesize carbon nanotubes, and thus carbon nanotubes having excellent physical properties can be continuously synthesized.

もつれた光子を生成するためのシステム及び方法

Absstract of: CN121444010A

Systems and methods for generating entangled photons are presented. The systems and methods generally utilize dopant molecules contained in a host material within a microcavity. The dopant molecules are generally associated with a ground state triplet (GST) electron manifold. When the dopant molecules are subjected to light, the electron state of the dopant molecules is excited to an excited triplet (EST) electron manifold. The electronic state then decays via a transition path that includes a zero phonon line (ZPL) electron transition. In the presence of the microcavity, the decay rate of electron transition along the ZPL is greatly enhanced. Thus, when the dopant molecules decay from the EST electron manifold to the GST electron manifold they emit photons having a nearly pure optical state (e.g., nearly pure wavelength and optical polarization). Thus, the optical state of the emitted photons correlates with the electronic state of the dopant molecules.

ウルトラキャパシタのためのエネルギー貯蔵媒体

Absstract of: AU2012267770A1

An ultracapacitor includes at least one electrode that includes carbon nanotubes. The carbon nanotubes may be applied in a variety of ways, and a plurality of layers may be included. Methods of fabrication of carbon nanotubes and ultracapacitors are provided.

カーボンナノチューブおよびハイブリッド材料を触媒化学蒸着を介して合成するためのシステムおよび方法

Absstract of: CN118215639A

Reactor systems and related methods configured to produce carbonaceous materials by exposing a carbonaceous reactant gas to catalyst particles. The reactor system includes a reactor containing a heated reaction volume wherein a reaction gas is exposed to catalyst particles, at least one reaction gas inlet into the reaction volume, and at least one catalyst particle inlet into the reaction volume. The catalyst particles are heated before they contact the reaction gas.

治療、イメージング、およびセラノスティック用途向けの小型超均一ナノ医薬組成物

Absstract of: WO2020056333A1

A targetable nanoconstruct capable of simultaneously serving as a therapeutic platform for photodynamic therapy as well as an MR molecular imaging agent, free of heavy metal atoms. F3-cys targeting agent nanoconstructs, including 8PEGA-Ce6 NCs. A label-free 8PEGA nanoconstruct that can be directly and selectively imaged by MRI, using standard spin-echo imaging sequences with large diffusion magnetic field gradients to suppress the water signal.

ポリマーナノ複合材料に基づくセンサの測定方法およびポリマーナノ複合材料に基づくセンサ

Absstract of: WO2025002505A1

The invention relates to a measuring method for sensors based on polymer nanocomposites. The method involves a measuring device which is connected to the sensor, an analysis module, a parameter-identification module, and a monitoring module, wherein a. in a first step, at least three different frequencies are selected within a specified frequency range, and the impedance of the sensor, which is excited in the selected frequencies, is then measured in the selected frequency range by means of the measuring device, b. in a second step, the measured impedance values are analyzed in order to determine an impedance model of the sensor by means of the analysis module, c. in a third step, the optimal measuring parameter is identified on the basis of the impedance model by means of the parameter-identification module, said optimal measuring parameter having the highest degree of sensitivity and selectivity for the excitation of the sensor, and d. the optimal measuring parameter is used by the monitoring module for a real-time monitoring of the sensor reaction in one or a plurality of the selected frequencies. The invention additionally relates to a sensor based on polymer nanocomposites, comprising a polymer nanocomposite sensor layer, said nanocomposite sensor layer having electrically conductive nanoparticles which are integrated into a polymer matrix. The nanoparticles have at least one dimension which is shorter than 130 nm, and an electrode structure is in contact with the polyme

一种半导体型单壁碳纳米管的纯化方法、高纯半导体型单壁碳纳米管及其应用

Absstract of: CN122540857A

本发明涉及一种半导体型单壁碳纳米管的纯化方法、高纯半导体型单壁碳纳米管及其应用；所述纯化方法包括如下步骤：在弱氧化性气体与第一惰性气体的混合气氛中，将固相单壁碳纳米管原料进行微波辐射处理，得到高纯半导体型单壁碳纳米管；通过所述弱氧化性气体与第一惰性气体的混合气氛，协同微波辐射处理，使得原料中金属型单壁碳纳米管被选择性氧化刻蚀，同时保证半导体型单壁碳纳米管的结构不被破坏，成功获得半导体型单壁碳纳米管的占比优选高达93％以上的产品，且所述纯化方法整体单壁碳纳米管的收率优选高达72％以上，为半导体芯片的制造提供了优质的原材料。

一种氮/磷/硫共掺杂的复合碳纳米片、制备方法及其应用

Absstract of: CN122540855A

本发明涉及碳材料制备技术领域，具体涉及一种氮/磷/硫共掺杂的复合碳纳米片、制备方法及其应用，以菜籽饼和煤沥青为碳源，三聚氰胺为氮源，磷酸二氢钾为磷源，硫酸钠为硫源，乙酸锌为模板兼催化剂；将菜籽饼、煤沥青、三聚氰胺、磷酸二氢钾、硫酸钠、乙酸锌混合均匀后置于碳化炉内，在氩气气氛下，加热制备氮/磷/硫共掺杂的复合碳纳米片。该复合碳纳米片的比表面积达710.8m2/g；总孔容达0.42cm3/g。作为钾离子电池负极材料，在0.8 M六氟磷酸钾(KPF6)电解液中，电流密度为0.1C时，比容量达395.2mAh/g；当电流密度增大至20C时，比容量达121.8mAh/g；在电流密度为5C时，循环1000次后，容量保持为143.2mAh/g。展现出优异的倍率性能，同时具备出色的循环稳定性。

一种红景天源碳点及其在周围神经损伤修复中的应用

Absstract of: CN122537400A

本发明提供一种红景天源碳点及其在周围神经损伤修复中的应用，涉及纳米材料技术领域，所述红景天源碳点（RD‑CDs）由一步水热法合成，制备工艺简单，且具有优良的理化性质、良好的生物安全性与抗氧化活性；在细胞层面可有效保护LPC诱导的神经元损伤，在动物层面可显著促进PNI后的神经再生、组织修复及运动/感觉功能恢复，且疗效优于红景天苷。本发明为神经损伤性疾病的防治提供了一种新型、安全的纳米制剂，具有重要的临床转化潜力与应用价值。

一种含硒碳量子点在强化水稻结实率中的应用

Absstract of: CN122536586A

本发明属于植物生长调节剂技术领域，具体公开了一种含硒碳量子点在强化水稻结实率中的应用。本发明将含硒碳量子点Se‑CDs作为水稻对抗高温热害的调节剂，通过叶面喷施方式应用于水稻栽培。实验表明，在灌浆期高温或自然高温条件下，Se‑CDs处理能够显著提高水稻的结实率、实粒数和花粉可育性，尤其是穗下部二次枝梗的花粉碘染率，并提升灌浆籽粒的抗氧化酶活性，其效果优于传统调理剂PMO和清水对照。本发明为缓解高温逆境导致的水稻减产问题提供了高效、低毒、环境友好的纳米硒调控技术，具有重要的农业生产应用前景。

一种具有光吸收特性的碳点薄膜及其制备方法与应用

Absstract of: CN122540853A

本发明公开一种具有光吸收特性的碳点薄膜及其制备方法与应用，涉及光吸收材料技术领域。本发明碳点薄膜的制备方法为：将有机胺和有机酸添加至有机溶剂中混合反应，反应结束进行过滤，取滤液作为碳点母液，将碳点母液透析，得到碳点溶液，将碳点溶液与溶剂混合，并添加分散剂复合，加热搅拌得到碳点分散液，随后浇注于模具，得到碳点薄膜；本发明制备得到的碳点薄膜具有高透明性和优异的紫外‑蓝光屏蔽性能，其中CDs/PVA薄膜兼具良好抗氧化性能，可用于果蔬保鲜；CDs/PVB薄膜兼具力学增强与光学调控功能，可用于安全玻璃夹层膜或表面光漫反射膜。本发明制备的碳点薄膜还可用于冷白光LED的光色调节。本发明制备方法简单，原料易得，兼具光学屏蔽、抗氧化及功能应用特性，具有良好的应用前景。

温敏型荧光纺织品及其制备方法

Absstract of: CN122543284A

本申请提供了一种温敏型荧光纺织品及其制备方法，属于功能纺织品领域，通过将氨基化合物和含硫有机物作为前驱体溶于溶剂中，经水热反应，得到硫氮掺杂的温敏型荧光碳点溶液；将得到的温敏型荧光碳点溶液负载于纺织基材表面，得到温敏型荧光纺织品。本申请采用水热合成法合成温敏型荧光碳点，工艺简便，原料成本低廉且易于获取，合成的碳点光学稳定性强、生物相容性好、温敏响应性好、表面修饰技术灵活，在紫外灯下可以显示优异的蓝白色荧光性能，不同温度下荧光强度显著改变；将其通过涂敷、浸渍或者喷涂的方式负载于纺织基材表面可制备温敏型荧光纺织品，在荧光防伪、智能穿戴、环境检测、生物医药等领域具有广阔的应用前景。

一种苯硼酸改性壳聚糖/芦荟苷抗菌水凝胶及其制备方法

Absstract of: CN122537581A

本发明涉及生物医用材料技术领域，具体涉及一种苯硼酸改性壳聚糖/芦荟苷抗菌水凝胶及其制备方法。具体技术方案为：该方法先采用4‑羧基苯硼酸对壳聚糖进行接枝改性，制得苯硼酸改性壳聚糖；再将壳聚糖衍生碳量子点分散于醋酸水溶液中，并用于溶解苯硼酸改性壳聚糖，得到含碳量子点的苯硼酸改性壳聚糖溶液；随后将其与芦荟苷溶液混合，在碱性条件下交联成胶，并经静置、水浴、透析和冷冻干燥得到目标产物。所得水凝胶兼具自愈合性能、抗菌性能和荧光示踪功能。该制备方法简便、条件温和，所得水凝胶在抗菌敷料、创面覆盖材料和功能生物医用材料领域具有应用价值。

具有广谱自由基清除能力的丹参-三七药渣碳点及其制备方法和应用

Absstract of: CN122540856A

本发明提供了一种具有广谱自由基清除能力的丹参‑三七药渣碳点及其制备方法和应用，该碳点以质量比为1:1的三七药渣和丹参药渣为原料，加入天然低共熔溶剂，再转移至反应釜，反应后经过过滤、透析和冷冻干燥得到丹参‑三七药渣碳点；其中，添加的天然低共熔溶剂的体积与三七药渣和丹参药渣的质量和的比为1:10μL/mg，天然低共熔溶剂为甜菜碱与乳酸按摩尔比1：1形成的体系。本发明所述的碳点具有较好的结构均一性和表面功能化特征，颗粒尺度处于纳米范围，表面富含含氧和含氮官能团，这些结构特征有利于其清除自由基。

一种超临界水制备碳量子点的连续化工艺及设备

Absstract of: CN122538040A

本发明公开一种超临界水制备碳量子点的连续化工艺及设备，属于纳米级碳材料制备技术领域。本发明以葡萄糖等为碳源、氨水等为氮掺杂剂、纯水为溶剂配制前驱体原液，经纯水稀释后，以0.1～50 L/h恒定流速连续送入超临界反应系统；制备反应条件为350～800℃、25～50 MPa，采用氮气作为惰性保护气氛；反应过程实时监测压力避免管路堵塞，产生的尾气导出室外，分段收集液相产物并以荧光法快速判定产物。本发明可实现碳量子点的连续、稳定、规模化制备，解决传统间歇水热/溶剂热法批次差、易堵管、安全性低、无法连续生产的问题，其工艺可控、设备运行安全、适合工业化放大。

一种利用光伏破碎硅片制备硅碳负极的方法

Nº publicación: CN122552488A 11/08/2026

Applicant:

陕西科技大学

Absstract of: CN122552488A

本申请公开了一种利用光伏破碎硅片制备硅碳负极的方法，属于光伏组件生产及锂离子电池储能材料领域。本申请对TOPCon和/或BC光伏产线产生的破碎硅片依次进行机械破碎处理和湿式纳米砂磨处理，获得纳米级硅颗粒；将所得纳米级硅颗粒与固液共相有机纳米碳源、石墨进行混合，得到混合物料；再将所得混合物料在非氧性气氛中进行煅烧处理，得到硅碳负极材料。本申请以光伏废弃破碎硅片为原料，实现了废料的高值化回收利用，大幅降低了原料成本；通过两级破碎可高效获得粒径≤100nm的纳米硅颗粒，有效抑制体积膨胀；工艺简单、能耗低，制得的硅碳负极容量可调、循环稳定性高，可适配不同储能场景需求。